Skip to main content Skip to main navigation menu Skip to site footer

Diagnosing TB-HIV co-infection: a case report in resource-limited setting

Abstract

Introduction: Human immunodeficiency virus (HIV) and tuberculosis (TB) often occur together with each exacerbating the other. In order to eradicate TB, TB/HIV co-infection must be addressed especially in resource-limited setting as this is becoming challenging at such area.

Case presentation: This article reports a 22 years old female with shortness of breath, cough, fever, and swelling int the neck area. Physical examination showed tachypnoea, hypoxaemia, oral candidiasis, and chest retraction. Chest X-ray showed miliary TB, anti-HIV antibody tests turned out reactive. FNAB result for lump on the neck show cytomorphological features suggest suppurative chronic inflammation, suggesting TB lymphadenitis. The patient was treated with antibiotics and anti-tuberculosis category I medications along with symptomatic treatment such as antifungal, blood transfusion, mucolytic agent, proton pump inhibitor, and steroid. ARV was given 2 weeks after the adaptation of anti-Tuberculosis regiments side effects and showed clinical remission.

Conclusion: TB-HIV constitutes a serious diagnostic and therapeutic challenge. In particular, this phenomenon weighs heavily on developing countries with strained health care budgets. In resource-limited settings, screening modalities focus more on clinical assessment rather than supporting diagnostics.

References

  1. Raviglione M, O’Brien RJ. Tuberculosis. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. McGraw-Hill. 2018;953–71.
  2. Amin Z, Bahar A. Tuberkulosis Paru. In: Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setiyohadi B, Syam AF, editors. Buku Ajar Ilmu Penyakit Dalam. Jakarta. 2014;863–80.
  3. Alzayer Z, Al Nasser Y. Primary Lung Tuberculosis. StatPearls - NCBI Bookshelf. 2022.
  4. WHO. Global Tuberculosis Report 2019. 2019.
  5. Kemenkes RI. Hasil utama RISKESDAS 2018. 2018. Available at: http//www depkes go id/resources/download/info-terkini/materi_rakorpop_2018/Hasil% 20Riskesdas 2018;202018.
  6. Dinas Kesehatan Provinsi Bali. Profil Kesehatan Provinsi Bali. Denpasar. 2017.
  7. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–56.
  8. Fry SH-L, Barnabas SL, Cotton MF. Tuberculosis and HIV—An Update on the “cursed duet” in children. Front Pediatr. 2019;7:159.
  9. Collins D, Hafidz F, Mustikawati D. The economic burden of tuberculosis in Indonesia. Int J Tuberc Lung Dis. 2017;21(9):1041–8.
  10. Organization WH. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization. 2018.
  11. Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis. 2014;14(1):1–10.
  12. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection—associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(Supplement_3):S201–7.
  13. Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64915.
  14. Méndez, Samperio P. Diagnosis of tuberculosis in HIV co‐infected individuals: current status, challenges and opportunities for the future. Scand J Immunol. 2017;86(2):76–82.
  15. Tornheim JA, Dooley KE. Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS. 2018;13(6):486–91.
  16. Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res. 2011;134(6):850–65.
  17. Tornheim JA, Dooley KE. Tuberculosis associated with HIV infection. Microbiol Spectr. 2017;5(1):1–5.
  18. Aljohaney A, Amjadi K, Alvarez GG. A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients. Clin Dev Immunol. 2012;2012.
  19. Letang E, Ellis J, Naidoo K, Casas EC, Sánchez P, Hassan-Moosa R, et al. Tuberculosis-HIV co-infection: progress and challenges after two decades of global antiretroviral treatment roll-out. Arch Bronconeumol 2020;56(7):446–54.
  20. Hamada Y, Getahun H, Tadesse BT, Ford N. HIV-associated tuberculosis. Int J STD AIDS. 2021;32(9):780–90.
  21. Nyaruhirira AU, Scholten JN, Gidado M, Suarez PG. COVID-19 Diagnosis in Low-and Middle-Income Countries: the big new bully disrupting TB and HIV diagnostic services. J Mol Diagnostics. 2022.
  22. World Health Organization. Guideline on when to start Antiretroviral Therapy and Pre-Exposure Prophylaxis for HIV. Geneva. 2015.

How to Cite

Praptika, N. L. P., & Suryana, K. . (2022). Diagnosing TB-HIV co-infection: a case report in resource-limited setting. Intisari Sains Medis, 13(3), 829–831. https://doi.org/10.15562/ism.v13i3.1511

HTML
0

Total
0

Share

Search Panel

Ni Luh Parameswari Praptika
Google Scholar
Pubmed
ISM Journal


Ketut Suryana
Google Scholar
Pubmed
ISM Journal